prostate cancer

Spotlight on: Exosome Diagnostics, first to develop RNA-based liquid biopsies
Wed, 06/5/19 - 04:00 pm
Exosome Diagnostics
diagnostics
Bio-Techne
prostate cancer
lung cancer
RNA
ASCO: Pfizer, Astellas' Xtandi racks up more data for new prostate cancer approval
Fierce Pharma
Sun, 06/2/19 - 01:17 pm
Pfizer
Astellas
Xtandi
prostate cancer
ASCO 2019
AZ/Merck & Co reveal data supporting PARP drug in prostate cancer
Pharmaforum
Sat, 06/1/19 - 12:43 pm
ASCO 2019
AstraZeneca
Merck
prostate cancer
olaparib
ASCO 2019 day one
Pharmaforum
Fri, 05/31/19 - 11:46 am
ASCO 2019
JNJ
Erleada
AstraZeneca
Merck
Lynparza
prostate cancer
Dendreon commits to prostate cancer vaccine Provenge with new lease for manufacturing site
Fierce Pharma
Thu, 05/23/19 - 09:59 am
Dendreon
prostate cancer
Provenge
drug manufacturing
Marketing J&J eyes prostate cancer boost as FDA accepts Erleada for real-time review
Fierce Pharma
Fri, 05/3/19 - 10:43 pm
JNJ
Erleada
FDA
prostate cancer
metastatic castration-resistant prostate cancer
FDA tags Bayer's prostate cancer drug for priority review as drugmaker gears up against rivals
Endpoints
Mon, 04/29/19 - 12:02 pm
Bayer
Orion
prostate cancer
priority review
daralutamide
FDA
miR Scientific Presents Urine Based Test for Detecting Prostate and Bladder Cancer
CP Wire
Mon, 03/18/19 - 10:28 am
miR Scientific
prostate cancer
bladder cancer
miR Scientific Presents Urine Based Test for Detecting Prostate and Bladder Cancer
Mon, 03/18/19 - 10:27 am
miR Scientific
prostate cancer
bladder cancer
Blood Test Study Meets Goal, Validates Epic’s Prostate Cancer Target
Xconomy
Thu, 03/14/19 - 09:52 am
Epic Sciences
diagnostics
prostate cancer
Bayer files prostate cancer drug darolutamide with EU regulators
Pharmaforum
Mon, 03/11/19 - 10:06 am
Bayer
Europe
darolutamide
prostate cancer
Bayer files prostate cancer drug darolutamide in Japan
Pharmaforum
Tue, 03/5/19 - 10:02 am
Bayer
prostate cancer
darolutamide
Japan
JNJ
Pfizer
Astellas
Bayer stresses drug's tolerability in bid for prostate cancer market
Yahoo/Reuters
Fri, 02/15/19 - 10:25 am
Bayer
prostate cancer
darolutamide
Pfizer
JNJ
Merck plans trio of Phase 3 Keytruda studies in prostate cancer
BioPharma Dive
Thu, 02/14/19 - 05:56 pm
Merck
Keytruda
prostate cancer
clinical trials
J&J scores another PhIII win for Erleada as it continues to build a blockbuster franchise
Endpoints
Wed, 01/30/19 - 11:47 am
JNJ
Erleada
prostate cancer
metastatic prostate cancer
European Commission Approves Janssen's Erleada for Patients at High Risk of Developing Metastatic Prostate Cancer
CP Wire
Wed, 01/16/19 - 10:03 am
Janssen
JNJ
Erleada
prostate cancer
Europe
European Commission Approves Janssen's Erleada for Patients at High Risk of Developing Metastatic Prostate Cancer
Wed, 01/16/19 - 09:52 am
Janssen
JNJ
Erleada
prostate cancer
Astellas and Pfizer's Xtandi Meets Primary Endpoint in Ph III Trial of Metastatic Prostate Cancer
CP Wire
Thu, 12/20/18 - 10:27 am
Astellas
Pfizer
Xtandi
prostate cancer
metastatic prostate cancer
Astellas and Pfizer's Xtandi Meets Primary Endpoint in Ph III Trial of Metastatic Prostate Cancer
Thu, 12/20/18 - 10:19 am
Astellas
Pfizer
Xtandi
prostate cancer
metastatic prostate cancer
Sophiris, Stock Sliding After Cancer Drug Data, Still Plans Phase 3
Xconomy
Mon, 12/17/18 - 08:18 pm
Sophris
prostate cancer
clinical trials
Topsalysin

Pages